A key advisory panel that oversees nationwide vaccine recommendations may vote to restrict access to hepatitis B ...
A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B ...
A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B ...
The nation's top vaccine advisory panel is expected to debate on Thursday whether to delay the first dose of the hepatitis B ...
Public health experts warn any delay to the newborn dose of the hepatitis B vaccine could threaten decades of progress.
PBGENE-HBV, the first gene editing therapy designed to treat chronic Hepatitis B by directly targeting HBV cccDNA and integrated HBV DNA, showcased as the final oral presentation in the late-breaking ...
A multidisciplinary research team at the University of Central Florida has received US $537,619 from the National Institutes of Health to advance a novel electrochemical biosensor capable of ...